Device Medical Device

(792) Multi Modality Ivus Other Systems

Payments companies reported to CMS as associated with (792) Multi Modality Ivus Other Systems. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$2,472associated payments (2023-2025)
73clinicians with associated payments
2companies reporting

By year

2023 $1,434
2024 $1,039

Payments reported as associated with (792) Multi Modality Ivus Other Systems, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Interventional Cardiology $464
Cardiovascular Disease $393
Vascular Surgery $312
Family $274
Vascular & Interventional Radiology $113
Nurse Practitioner $104

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with (792) Multi Modality Ivus Other Systems

These are the largest totals companies reported as associated with (792) Multi Modality Ivus Other Systems. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Thomas Davis St Clair Shores, MI Cardiovascular Disease $179.24
James Zimmerman Redwood City, CA Vascular Surgery $94.67
Ashkan Karimi Manassas, VA Interventional Cardiology $89.36
Massoud Arbabzadeh Garden Grove, CA Vascular & Interventional Radiology $89.36
Naren Gupta Hyannis, MA Vascular Surgery $89.36
Craig Walker Houma, LA Interventional Cardiology $75.28
Christopher Stout Rogers, AR Vascular Surgery $73.72
Robert Stauffer Joplin, MO Cardiovascular Disease $56.75
Grant Scott Springfield, MO Vascular Surgery $54.37
Anne Herrick Scarborough, ME Adult Health (Nurse Practitioner) $49.05

Prescribed (792) Multi Modality Ivus Other Systems?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.